Top 50 Dna Data Storage in LATAM

Cache DNA develops next-generation biopreservation technologies to support breakthroughs in the life sciences. The company focuses on storing biomolecules at unprecedented scales, moving beyond traditional freezer storage methods. This advanced preservation supports high-quality biospecimens necessary for clinical research, assay development, and personalized therapies.

OmnigenicsAI is an AI-driven genomics company that provides secure, precise biological data to empower individuals in managing their health through personalized genomic insights. Their services include specialized genetic testing and telemedicine consultations, enabling proactive health management and informed healthcare decisions across all life stages.

Elegen utilizes proprietary cell-free DNA synthesis technology to produce long, complex, linear DNA up to 7 kb with 99.999% accuracy, eliminating the need for cloning. This rapid synthesis, delivered in 6 to 8 business days, addresses the critical bottleneck in DNA supply for synthetic biology applications, significantly reducing project timelines and costs.

Engage Bio develops Tethosomes, a non-viral DNA platform designed to overcome potency and toxicity limitations in genetic medicine delivery. This technology utilizes LNP delivery to express a proprietary protein that tethers therapeutic DNA to the nucleus, achieving over 100x expression while remaining non-immunogenic. The platform enables potent, durable, and safely redosable DNA medicines scalable for therapeutic applications across gene replacement and oncology.

Provides a blockchain-based platform that integrates AI, IoT, and satellite technology to help smallholder farmers optimize operations, improve crop yields, and ensure compliance with regulations like the EU's deforestation law. The system offers tools for farm management, livestock genetics tracking, supply chain transparency, and access to decentralized finance (CeDeFi) services, enabling farmers to increase profitability and sustainability.

Clear Labs is a biotechnology firm that utilizes a genomics system to enhance diagnostic accuracy in clinical and application sectors. The company addresses the complexity of traditional diagnostic processes by providing streamlined genomic analysis, enabling faster and more reliable results.

The startup facilitates secure and decentralized information exchange using blockchain technology to ensure data integrity and privacy. This approach addresses the challenges of data centralization and unauthorized access, enabling users to share sensitive information confidently.

Single Helix Genomics has developed an automated, portable device that delivers therapeutics on demand, utilizing advanced genomic technologies for precise treatment applications. This device addresses the need for immediate and personalized therapeutic solutions in various medical settings, enhancing patient care and treatment efficiency.

The startup offers a data management platform that automates the secure processing of information, enabling users to exchange private data between individuals, businesses, and financial institutions while adhering to compliance standards. This solution significantly reduces onboarding and financial product closing cycles, enhancing the efficiency of commercial, legal, and risk processes.

Provides end-to-end encrypted cloud storage with zero-knowledge AES-256 encryption, ensuring that only users can access their data. By fragmenting and encrypting files before they leave the device, it protects against unauthorized access, data leaks, and breaches, making it a secure alternative to traditional cloud services.

Embryoxite develops an AI-powered platform that analyzes embryo metabolomic data, genetic profiles, and morphokinetic imaging to assess implantation potential in pre-implantation embryos. This technology addresses the high failure rate of embryo implantation in IVF procedures by providing objective, data-driven insights that enhance selection accuracy and improve pregnancy outcomes.

This biotech startup produces highly pure enzymes using recombinant DNA repair technology derived from Antarctic extremophiles, enabling large-scale replication of active ingredients. Their offerings provide clinicians with effective alternatives for skin health and rejuvenation in the cosmetic and pharmaceutical industries.

Clumio provides a serverless, agentless platform for autonomous backup and recovery of AWS data, ensuring data immutability and air-gapped storage to protect against ransomware and operational disruptions. By optimizing backup processes, Clumio helps enterprises reduce storage costs by over 30% while maintaining compliance with stringent data regulations.

This startup offers a digital platform for securely storing and accessing personal medical histories, allowing users to manage their health information anytime and anywhere. By providing a centralized, easily accessible record, it addresses the challenge of fragmented medical data, enhancing patient empowerment and continuity of care.

The startup specializes in identifying bioactive ribonucleic acid (RNA) from natural sources using machine learning and bioinformatics techniques. This enables researchers to enhance human health and resilience in response to environmental stressors through the application of RNA technologies.

Antarka develops and supplies a highly pure, skin-permeable enzyme ingredient for the dermocosmetic industry. This active ingredient is sourced from resilient organisms and is clinically proven to actively repair UV-induced DNA damage in the skin. The company provides cosmetic brands with a high-performance active that improves skin elasticity, firmness, and overall appearance.

Excelero Storage provides software-defined block storage through its NVMesh solution, enabling high-performance data management for cloud and enterprise applications. This technology addresses the challenges of scalability and efficiency in data storage, allowing organizations to optimize their infrastructure while reducing latency and costs.

The startup develops financial market infrastructure that enhances the security and efficiency of receivables management through advanced data analysis and secure data storage. By providing clarity on valuation, formalization, and financial flow control, the company enables clients to optimize credit operations and reduce uncertainties in their financial transactions.

Qdrant provides an open-source vector search database that enables high-performance similarity searches for high-dimensional data, facilitating the development of applications for matching, searching, and recommending. By efficiently processing embeddings from neural networks, Qdrant allows businesses to leverage unstructured data for enhanced data analysis and personalized user experiences.

The startup develops deep sub-threshold analog in-memory computation semiconductors that execute data-center-grade AI workloads with significantly lower power consumption and no active cooling. This technology processes data within memory, enabling industries to efficiently handle complex tasks while minimizing energy use.

Olympics Cloud provides a cloud computing platform tailored for B2B and B2C applications, enabling businesses to efficiently manage and scale their operations. The solution addresses the challenges of data storage, processing, and accessibility, ensuring reliable performance for users across various industries.

TARIC provides a cloud-based EHR platform that streamlines patient data management for medical professionals. It offers secure access to patient histories, integrated teleconsultations, and digital signature capabilities to improve diagnostic accuracy and workflow efficiency.

This company develops co-processors utilizing biological neurons as an alternative to traditional silicon-based computing. Their neuron systems offer adaptable architecture, stable power consumption, and high fault tolerance compared to fixed transistor systems. These bio-processors are applied across security, military, and agriculture sectors for advanced sensory detection and analysis.

Rosebud Biosciences develops targeted therapies for rare pediatric genetic diseases using patient-specific organoid models. The company engineers micropatterned 2.5D organoids from induced pluripotent stem cells that replicate individual genetic mutations for drug screening. This platform enables the high-throughput testing of small molecules, gene therapies, and RNA therapeutics against complex developmental disorders.

The startup has developed a molecular testing platform that utilizes low-cost tools for on-site analysis of DNA, RNA, and protein targets. This technology enables businesses to make real-time decisions regarding food quality and health by providing precise and accessible testing services.

Precision Data provides a business intelligence platform that utilizes generative artificial intelligence to optimize access to over 8 billion lines of structured clinical data, enhancing real-world evidence studies in healthcare. The company addresses the challenge of data quality and accessibility, enabling healthcare organizations to make informed decisions based on accurate and comprehensive information.

SciCrop is a big data analytics platform that integrates internal, supplier, and IoT data to provide tailored dashboards and machine learning insights for agricultural operations. The platform enables farmers and agribusinesses to enhance productivity and decision-making through real-time geographic and weather analytics.

DNA Financeiro offers a cloud-based ERP platform that integrates financial management, inventory control, and CRM functionalities specifically designed for small and medium-sized businesses. The platform simplifies accounting processes by providing real-time insights, automated tax compliance, and seamless communication with certified accountants, addressing the challenges of financial oversight and regulatory compliance for entrepreneurs.

Comsentimento develops an AI-driven platform for clinical data transformation and research, focusing on enhancing cancer treatment and facilitating access to clinical trials. The platform provides healthcare professionals with actionable insights and support for chronic disease management, improving patient care and treatment adherence.

The startup has developed a clinical research platform that utilizes machine learning to target the biological processes of aging, facilitating the discovery of therapies for age-related diseases such as cardiovascular and neurodegenerative conditions. By enabling pharmaceutical companies to enhance medical treatments, the platform addresses the need for more effective interventions in aging-related health issues.

ReachUp! provides an indoor location and proximity marketing platform utilizing IoT technology and data visualization to enhance customer experiences in retail and cultural spaces. The solution enables real-time navigation, personalized promotions, and accessibility feedback, addressing the need for improved engagement and data-driven decision-making in complex environments.

SPAKIO offers on-demand storage services by collecting, securely storing, and delivering items to customers in Mexico City. They utilize a pay-per-use model, charging only for the utilized space, which contrasts with traditional self-storage rentals. Customers manage their stored inventory digitally through an application for convenient retrieval requests.

This startup provides biotechnology services focused on developing industrial yeast strains and optimizing fermentation processes through advanced yeast metabolism and genetics research. Their solutions enable the yeast and fermentation industries to produce environmentally friendly products using renewable resources, addressing the need for sustainable manufacturing practices.

MEDiC utilizes a proprietary CRISPR functional genomics platform combined with 3D tumor models to identify cancer biomarkers and novel drug targets with high precision. This approach addresses the challenge of missed potential biomarkers in current drug development, enhancing the accuracy of patient stratification for oncology treatments.

Phinomics provides a patented platform that isolates and decodes extrachromosomal circular DNA and cryptic micro-proteins, which are key drivers in cancer and immune dysfunction. This technology reveals previously invisible biology that conventional sequencing methods miss, offering a more complete view of disease mechanisms. By integrating these causal elements, the company aims to enable more accurate target discovery for next-generation therapeutics.

This biotechnology platform decodes microbiomes to identify and manage their potential in productive environments. By providing insights from microbiome data, the platform helps researchers make informed decisions to minimize environmental impact and enhance performance.

Base Cientifica offers comprehensive molecular and cellular research services to accelerate preclinical development and personalized medicine. They specialize in biological assay validation, biobanking, and molecular diagnostic assay development using PCR and NGS. Their services also include preclinical efficacy and safety studies, 3D organoid cultivation, and AI-driven R&D optimization.

The startup offers a document management platform that digitizes paper documents and secures them on Amazon's cloud infrastructure, enabling efficient digital accounting and business process management. This solution allows public and private institutions to streamline operations and reduce administrative overhead, resulting in a more agile and cost-effective model for document handling.

Vlab provides a digital platform for the collection, organization, and exploration of medical video data, including ultrasound and endoscopy recordings. This technology replaces outdated storage methods, enabling healthcare providers to enhance patient experiences, improve diagnostic accuracy, and facilitate medical education through structured datasets.

The startup operates a genomics platform that centralizes and integrates DNA data to provide precise diagnoses and personalized treatment plans through advanced data analysis and interpretation. By leveraging genomic information, the platform enables researchers to enhance health outcomes and preventive care strategies for individuals.

Beeing Company utilizes artificial intelligence and neural networks to perform genetic analysis of honey bee queens, ensuring the preservation of bee species and promoting biodiversity. Their certification process guarantees that beekeepers can verify the quality and health of their bees, facilitating access to international markets.

Bluwhale is a decentralized knowledge data platform that allows decentralized applications (DApps) to enhance their functionality through API calls. It empowers users to control their data and exchange it for value, creating a more equitable digital identity ecosystem.

Mushroom Protocol utilizes decentralized finance and smart contracts to connect early-stage biotechnology companies with global investors, enabling fractional ownership of intellectual property and equity. This approach addresses the challenge of securing funding for biotech startups while allowing them to maintain control over their innovations.

The startup has developed a molecular diagnostic platform that integrates advanced fluidics, engineering, and bioinformatics to create a user-friendly in vitro diagnostic system. This technology enables healthcare providers to deliver precise clinical genomic information to patients, enhancing accessibility to essential diagnostics for improved treatment outcomes.

SpotMe is an online marketplace that connects individuals and businesses with unused storage spaces, utilizing a secure, fully digital platform that incorporates identity verification processes. The service addresses the high demand for affordable and convenient storage solutions in LATAM by allowing hosts to monetize their unused spaces while providing renters with quick access to various storage options.

Scout provides molecular diagnostic testing that achieves 99% agreement with high-complexity PCR results in 30 minutes. This patented technology eliminates the trade-off between accuracy, speed, and cost often seen in traditional diagnostics. The ultra-portable system enables decisive, near-patient diagnosis and treatment in various care settings.

This startup provides personalized medicines through genetic testing and data analysis, enabling microgram-level customization of treatments. By tracking the entire treatment journey, it offers patients affordable, tailored medications and real-time updates on their health status.

TAXON utilizes artificial intelligence and genomic analysis to enhance soil microbiome understanding, enabling farmers and biotech companies to optimize crop yields and reduce reliance on agrochemicals. By providing detailed insights into microbial diversity and functionality, TAXON helps clients make informed decisions that lead to sustainable agricultural practices and improved productivity.

Aptos Solar Technology manufactures high-efficiency solar panels utilizing patented Dual Nano Absorber (DNA) technology, which enhances performance and heat tolerance while reducing manufacturing costs. The company addresses the need for reliable and affordable solar energy solutions for residential, commercial, and utility applications, backed by rigorous quality testing and industry-leading warranties.

The startup develops gene therapies utilizing a biocompatible delivery system to facilitate targeted treatment of genetic diseases. This approach enhances the efficacy of therapeutic interventions, addressing the limitations of traditional treatment methods in the biotechnological market.